検索ワード: hsct (英語 - デンマーク語)

response durations are confounded in patients who received a hsct.
varighed af respons er konfunderet hos patienter, der fik hsct.

the first dose was administered at 3 to 6 months after hsct.
den første dosis blev indgivet 3-6 måneder efter stamcelletransplantationen.

hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (hsct).
hypogammaglobulinæmi hos patienter efter allogen hæmatopoietisk stamcelletransplantation (hsct).

the primary endpoint was the rate of occurrence of proven and probable ifi during the first year after hsct.
det primære effektmål var forekomsten af påvist og sandsynlig invasiv svampeinfektion i det første år efter hsct.

- hematopoietic stem cell transplant (hsct) recipients who are undergoing high-dose
- modtagere af hematopoietisk stamcelle transplantation (hsct), der undergår en høj- dosis

immune reconstitution defined as circulating t lymphocytes ≥100 per μl at the day of planned infusion after haploidentical hsct.
immunrekonstitution defineret som cirkulerende t-lymfocytter ≥100/μl på dagen for den planlagte infusion efter haploidentisk hsct.

fifteen of 36 (41.7%) patients had undergone allogeneic hsct prior to receiving blincyto.
femten ud af 36 (41,7 %) patienter havde gennemgået allogen hsct, inden de fik blincyto.

there is limited clinical experience of the use of busulfan as a component of a conditioning regimen prior to hsct in children with fanconi’s anaemia.
der er kun begrænset klinisk erfaring med anvendelse af busulfan som en del af et konditionerende regimen inden hpct hos børn med fanconis anæmi.

patients treated prophylactically with micafungin were those undergoing haematopoetic stem cell transplantation (hsct) who were at high risk for fungal infections.
patienter, der fik profylaktisk behandling med micafungin, var de, som gennemgik en hæmatopoetisk stamcelletransplantation (hsct), og som havde en høj risiko for at få svampeinfektion.

patients, especially children, with risk factors for acute pancreatitis (e. g. recent chemotherapy, hematopoietic stem cell translplantation (hsct)), should be monitored closely during vfend treatment.
patienter, især børn med risikofaktorer for akut pancreatitis (f. eks. nylig kemoterapi, hæmatopoietisk stamcelletransplantation (hsct)) bør monitoreres tæt under vfend- behandling.